Richard Paul Bryce, SEE REMARKS at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 1,841 shares at $10.10 ($19K) on 2019-07-22, disclosed to the SEC on 2019-07-24.
Scheduled sale ($19k) by SEE REMARKS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PBYI | SELL | 2021-02-03 | $5K | — | Filing → |
| PBYI | SELL | 2021-01-06 | $134K | — | Filing → |
| PBYI | SELL | 2020-12-04 | $1K | — | Filing → |